Benign Prostatic Hyperplasia Prostate Treatment Market Size

Benign Prostatic Hyperplasia Prostate Treatment Market size was over USD 7.86 billion in 2024 and is likely to cross USD 16.09 billion by the end of 2037, growing at more than 5.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of benign prostatic hyperplasia prostate treatment is estimated at USD 8.22 billion. The growth of the market can primarily be ascribed to the growing rate of BPH surgical treatment since it can cost one’s life. Moreover, it is a disorder that is generally observed in men around the world, it is anticipated to increase the market’s growth. For instance, nearly 200,000 prostatectomy procedures are carried every year for benign diseases in the United States.

Global benign prostatic hyperplasia (BPH) prostate treatment market trends such as, the higher prevalence of benign prostatic hyperplasia (BPH) and rising awareness of the disease are estimated to hike the growth of the market over the forecast period. Moreover, benign prostatic hyperplasia has been accepted as an increasing health problem among aged men, and it is predicted to increase the market’s growth in the upcoming years.  For instance, benign prostatic hyperplasia becomes more prevalent in men after the age of 40 with a prevalence rate of approximately 10% to 65% across the globe.